Pabla BS, Alex Wiles C, Slaughter JC, Scoville EA, et al. Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor alpha Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience. Dig Dis Sci 2022;67:3129-3137.
PMID: 34268660